Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Waxman/Hatch Reform Bill Needed Despite FDA’s Rule – McCain, Schumer

Executive Summary

Legislation to reform the generic drug approval process will still be needed following issuance of FDA's final rule, Sens. John McCain (R-Ariz.) and Charles Schumer (D-N.Y.) said
Advertisement

Related Content

Medicare Law Puts Rx In Spotlight Of Presidential Campaign Politics
Medicare Law Puts Rx In Spotlight Of Presidential Campaign Politics
Senate Generic Reform Bill Likely To Result In Earlier ANDA Filings
Blue Cross/Blue Shield Testing Generic Drug Ad Themes For 2003
Blue Cross/Blue Shield Testing Generic Drug Ad Themes For 2003
Advertisement
UsernamePublicRestriction

Register

PS041546

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel